Ph.D. Program for Cancer Molecular Biology and Drug Discovery

  • No. 250 Wu-Xing Street

    11031 Taipei

Organization profile

Organisation profile

This doctoral research program was established in collaboration with Academia Sinica to cultivate interdisciplinary research that focuses on tumor-related medicine. Academia Sinica is Taiwan’s leading research institute and has outstanding scientific researchers and cutting-edge equipment for advanced research. TMU also works in collaboration with its three affiliated hospitals and has access to their clinical resources.

Through these relationships, the Cancer Biology and Drug Discovery program offers students a great opportunity to build a career with excellent research support. We enroll top students from around the world, and provide a strong curriculum of interdisciplinary training as well as a learning environment where students work with many research specialists.

From basic research to translational medicine, we develop cutting-edge therapeutic strategies for cancer prevention and treatment. We work hard for cancer patients, seeking to extend their lives and improve their quality of life.

Fingerprint Dive into the research topics where Ph.D. Program for Cancer Molecular Biology and Drug Discovery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

    研究PKLR促進前列腺癌神經內分泌分化之代謝途徑及其治療角色(1/3)

    Liu, Y.

    8/1/207/1/21

    Project: A - Government Institutionb - Ministry of Science and Technology

    針對PD-L1 表現機制所發展出之口腔癌治療策略(2/3)

    Lin, H.

    8/1/207/1/21

    Project: A - Government Institutionb - Ministry of Science and Technology

    探討長鏈非編碼RNA LncHIFCAR-HIF1A 基因調控網路及其於口腔癌進程之臨床價值(2/2)

    Shih, J.

    8/1/207/1/21

    Project: A - Government Institutionb - Ministry of Science and Technology

    Research Output

    A site-moiety map and virtual screening approach for discovery of novel 5-LOX inhibitors

    Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., Dec 1 2020, In : Scientific Reports. 10, 1, 10510.

    Research output: Contribution to journalArticle

    Open Access
  • Astragalus membranaceus-Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors

    Chang, F. L., Tsai, K. C., Lin, T. Y., Yang, T. W., Lo, Y. N., Chen, W. C., Chang, J. H., Lu, M. K., Chiou, C. T., Chen, P. H., Yen, Y., Pan, S. L. & Lee, Y. C., Jan 1 2020, In : BioMed Research International. 2020, 3415471.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Citations (Scopus)

    CC12 induces apoptotic cell death and cell cycle arrest in human glioblastoma cell lines and mouse xenograft model

    Fann, L. Y., Shih, J. H., Tseng, J. H., Huang, H. S. & Hsiao, S. H., Apr 2020, In : Molecules. 25, 8, 25081793.

    Research output: Contribution to journalArticle

    Open Access